Survival status and predictors of mortality among COVID-19 patients admitted to intensive care units at COVID-19 centers in Addis Ababa, Ethiopia: a retrospective study

Author:

Boka Abdissa1,Tadesse Addisu2,W/Yohannes Getachew3,Hussein Kedir4

Affiliation:

1. School of Nursing & Midwifery, College of Health Science, Addis Ababa University

2. School of Public Health, Unity University

3. Department of Public Health, Yekatit 12 Hospital Medical College

4. Biostatics and Health Informatics, Public Health Department, Madda Walabu University, Addis Ababa, Ethiopia

Abstract

Introduction: Worldwide, including in Ethiopia, there is an increased risk of coronavirus disease 2019 (COVID-19) disease severity and mortality. This study aimed to assess the survival status and predictors of mortality among COVID-19 patients admitted to the intensive care unit. Methods: This study included 508 COVID-19 patients retrospectively who were under follow-up. The work has been reported in line with the STROCSS (strengthening the reporting of cohort, cross-sectional and case–control studies in surgery) criteria. The data were collected through a systematic sampling from patients’ charts. Kaplan–Meier survival curves and logrank test, and Cox’s regression analyses were conducted to check the difference among categories of covariates and to identify predictors of mortality, respectively. Results: All patient charts were reviewed and the information was recorded. The average age (mean+SD) of these patients was 62.1+13.6 years. Among study participants, 422 deaths occurred and the mortality rate was 64.1 per 1000 person-days. The median survival time was 13 days [interquartile range (IQR): 10–18]. The significant predictors for this survival were: Age>45 years [adjusted hazard ratio (AHR)=4.34, 95% CI: 2.46–7.86], Diabetes mellitus (AHR=1.37, 95% CI: 1.05–1.77), Hypertension (AHR=1.39, 95% CI: 1.09–1.79), Renal disease (AHR=1.86, 95% CI: 1.01–3.43), Hypotension (AHR=1.71, 95% CI: 1.28–2.27), Electrolyte treatment (AHR=0.78, 95% CI: 0.63–0.97). Conclusion: The median survival of COVID-19 patients after their admission was 13 days, and predictors for this time were advanced age, preexisting comorbidities (like diabetes mellitus, hypertension, and renal disease), hypotension, and electrolyte therapy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3